GP2 - Open Forum

I've been looking into FDA approved drugs for malaria and wondering if anyone has done any research on them relating to Leukemia. Can anyone help me find some information? I'm hopping to find some good labs to collaborate around this topic.

------------------------------
Greg Pollack
Account Executive
Higher Logic
Baltimore MD
------------------------------

I've done extensive research in this field and even presented at the AACR Conference in San Diego back in 2014. Check out my journal article.

Abstract 818: Repurposing Artemisinins for treatment of acute leukemias

Cancer Research		remove preview
Abstract 818: Repurposing Artemisinins for treatment of acute leukemias Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA More effective, less toxic treatments are needed to improve quantitative and qualitative outcomes for patients with acute leukemias. Drug repurposing has been validated as a productive approach in which the pharmacologic and safety information available for established drugs promotes their rapid translation to human clinical trials for a new indication. View this on Cancer Research >

http://cancerres.aacrjournals.org/content/74/19_Supplement/818 

------------------------------
Jennifer Fox
None
------------------------------

Original Message:
Sent: 04-12-2019 09:30
From: Greg Pollack
Subject: Has anyone tried repurposing Artemisinins for leukemia treatment?

I've been looking into FDA approved drugs for malaria and wondering if anyone has done any research on them relating to Leukemia. Can anyone help me find some information? I'm hopping to find some good labs to collaborate around this topic.

------------------------------
Greg Pollack
Account Executive
Higher Logic
Baltimore MD
------------------------------

Original Message------

I've done extensive research in this field and even presented at the AACR Conference in San Diego back in 2014. Check out my journal article.

Abstract 818: Repurposing Artemisinins for treatment of acute leukemias

Cancer Research		remove preview
Abstract 818: Repurposing Artemisinins for treatment of acute leukemias Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA More effective, less toxic treatments are needed to improve quantitative and qualitative outcomes for patients with acute leukemias. Drug repurposing has been validated as a productive approach in which the pharmacologic and safety information available for established drugs promotes their rapid translation to human clinical trials for a new indication. View this on Cancer Research >

http://cancerres.aacrjournals.org/content/74/19_Supplement/818 

------------------------------
Jennifer Fox
None
------------------------------